SPI Infoamtion

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?

3 In Vitro Diagnostics In South Africa
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, South Africa, Company Share (2008-2009)

4 Clinical Chemistry In South Africa
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, South Africa, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
4.4.2 Urine Analysis Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, South Africa, Company Share (2008-2009)

5 Genetic Testing In South Africa
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, South Africa, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, South Africa, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, South Africa, Company Share (2008-2009)

6 Haematology In South Africa
6.1 Haematology, Market Segmentation
6.2 Haematology Market, South Africa, Revenue Mix ($m), 2009
6.3 Haematology Market, South Africa, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.4.1 Haematology Reagents Revenue (2002-2016)
6.4.2 Immunohaematology Revenue (2002-2016)
6.4.3 Haemostasis Revenue (2002-2016)
6.4.4 Haematology Rapid Tests Revenue (2002-2016)
6.4.5 Haematology Cell Counters Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, South Africa, Company Share (2008-2009)

7 Histology And Cytology In South Africa
7.1 Histology and Cytology, Market Segmentation
7.2 Histology and Cytology Market, South Africa, Revenue Mix ($m), 2009
7.3 Histology and Cytology Market, South Africa, Category Contribution (%), 2009
7.4 Histology And Cytology Overall Revenue (2002-2016)
7.4.1 Histology Revenue (2002-2016)
7.5 Histology And Cytology Distribution Share (2008-2009)
7.6 Histology And Cytology, South Africa, Company Share (2008-2009)

8 Immuno Chemistry In South Africa
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, South Africa, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
8.4.2 Drug Related Testing Revenue (2002-2016)
8.4.3 Endocrinology Tests Revenue (2002-2016)
8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, South Africa, Company Share (2008-2009)

9 Infectious Immunology In South Africa
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, South Africa, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, South Africa, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, South Africa, Company Share (2008-2009)

10 Microbiology Culture In South Africa
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, South Africa, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, South Africa, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.4.1 Microbiology Analyzers Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, South Africa, Company Share (2008-2009)

11 Overview of Key Companies in South Africa In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the South Africa In Vitro Diagnostics Market
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Share in the South Africa In Vitro Diagnostics Market
11.3 bioMerieux S.A.
11.3.1 Company Overview
11.3.2 Share in the South Africa In Vitro Diagnostics Market
11.4 Ortho-Clinical Diagnostics Inc.
11.4.1 Company Overview
11.4.2 Share in the South Africa In Vitro Diagnostics Market
11.5 Siemens Healthcare
11.5.1 Company Overview
11.5.2 Share in the South Africa In Vitro Diagnostics Market
11.6 Beckman Coulter, Inc.
11.6.1 Company Overview
11.6.2 Share in the South Africa In Vitro Diagnostics Market
11.7 Inverness Medical Innovations, Inc.
11.7.1 Company Overview
11.8 Becton, Dickinson and Company
11.8.1 Company Overview
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Company Overview
11.10 Hologic, Inc.
11.10.1 Company Overview
11.11 OLYMPUS CORPORATION
11.11.1 Company Overview
11.12 Mindray Medical International Limited
11.12.1 Company Overview
11.13 Sysmex Corporation
11.13.1 Company Overview
11.14 DiaSorin S.p.A
11.14.1 Company Overview
11.15 Qiagen N.V.
11.15.1 Company Overview
11.16 Gen-Probe Incorporated
11.16.1 Company Overview
11.17 Phadia AB
11.17.1 Company Overview
11.18 Makromed Manufacturing (Pty) Ltd
11.18.1 Company Overview

12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products

13 Financial Deals Landscape
13.1 Partnerships
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
13.1.5 HairDX Enters Into Distribution Agreement With HairOptions
13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal

14 Recent Developments
14.1 Product News
14.1.1 Jan 11, 2010: HairDX Forms Alliance For Distribution Of HairDX Genetic Test In South Africa

15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer

List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016
Figure 3: In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2009
Figure 4: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009
Figure 5: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2002-2016
Figure 6: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Historic, 2002-2009
Figure 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Forecast, 2009-2016
Figure 8: In Vitro Diagnostics, South Africa, Company Share (%), 2009
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2009
Figure 11: Clinical Chemistry Market, South Africa, Category Contribution (%), 2009
Figure 12: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 13: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 14: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 15: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 16: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 17: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 18: Clinical Chemistry, South Africa, Company Share (%), 2009
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, South Africa, Revenue Mix ($m), 2009
Figure 21: Genetic Testing Market, South Africa, Category Contribution (%), 2009
Figure 22: Genetic Testing, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 23: Genetic Testing, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 24: Genetic Testing, South Africa, Company Share (%), 2009
Figure 25: Haematology, Market Segmentation
Figure 26: Haematology Market, South Africa, Revenue Mix ($m), 2009
Figure 27: Haematology Market, South Africa, Category Contribution (%), 2009
Figure 28: Haematology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 29: Haematology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 30: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 31: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 32: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 33: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 34: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 35: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 36: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 37: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 38: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 39: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 40: Haematology, South Africa, Company Share (%), 2009
Figure 41: Histology and Cytology, Market Segmentation
Figure 42: Histology and Cytology Market, South Africa, Revenue Mix ($m), 2009
Figure 43: Histology and Cytology Market, South Africa, Category Contribution (%), 2009
Figure 44: Histology And Cytology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 45: Histology And Cytology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 46: Histology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 47: Histology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 48: Histology And Cytology, South Africa, Company Share (%), 2009
Figure 49: Immuno Chemistry, Market Segmentation
Figure 50: Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2009 1
Figure 51: Immuno Chemistry Market, South Africa, Category Contribution (%), 2009
Figure 52: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 53: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 54: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 55: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 56: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 57: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 58: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 59: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 60: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 61: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 62: Immuno Chemistry, South Africa, Company Share (%), 2009
Figure 63: Infectious Immunology, Market Segmentation
Figure 64: Infectious Immunology Market, South Africa, Revenue Mix ($m), 2009
Figure 65: Infectious Immunology Market, South Africa, Category Contribution (%), 2009
Figure 66: Infectious Immunology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 67: Infectious Immunology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 68: Infectious Immunology, South Africa, Company Share (%), 2009
Figure 69: Microbiology Culture, Market Segmentation
Figure 70: Microbiology Culture Market, South Africa, Revenue Mix ($m), 2009
Figure 71: Microbiology Culture Market, South Africa, Category Contribution (%), 2009
Figure 72: Microbiology Culture, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Figure 73: Microbiology Culture, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 74: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 75: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 76: Microbiology Culture, South Africa, Company Share (%), 2009
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 78: Abbott Laboratories, Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 79: bioMerieux S.A., Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 80: Ortho-Clinical Diagnostics Inc., Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 81: Siemens Healthcare, Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 82: Beckman Coulter, Inc., Company Share (%),South Africa In Vitro Diagnostics Market, 2009
Figure 83: GlobalData Methodology

List of Tables
Table 1: In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016
Table 2: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009
Table 3: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2002-2016
Table 4: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Historic, 2002-2009
Table 5: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Forecast, 2009-2016
Table 6: In Vitro Diagnostics, South Africa, Company Share by Revenue ($m), 2008-2009
Table 7: Clinical Chemistry Market, South Africa, Category Contribution (%), 2009
Table 8: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 9: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 10: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 11: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 12: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 13: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 14: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 15: Clinical Chemistry, South Africa, Company Share by Revenue ($m), 2008-2009
Table 16: Genetic Testing Market, South Africa, Category Contribution (%), 2009
Table 17: Genetic Testing, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 18: Genetic Testing, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 19: Genetic Testing, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 20: Genetic Testing, South Africa, Company Share by Revenue ($m), 2008-2009
Table 21: Haematology Market, South Africa, Category Contribution (%), 2009
Table 22: Haematology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 23: Haematology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 24: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 25: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 26: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 27: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 28: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 29: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 30: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 31: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 32: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 33: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 34: Haematology, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 35: Haematology, South Africa, Company Share by Revenue ($m), 2008-2009
Table 36: Histology and Cytology Market, South Africa, Category Contribution (%), 2009
Table 37: Histology And Cytology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 38: Histology And Cytology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 39: Histology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 40: Histology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 41: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 42: Histology And Cytology, South Africa, Company Share by Revenue ($m), 2008-2009
Table 43: Immuno Chemistry Market, South Africa, Category Contribution (%), 2009
Table 44: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 45: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 46: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 47: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 48: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 49: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 50: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 51: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 52: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 53: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 54: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 55: Immuno Chemistry, South Africa, Company Share by Revenue ($m), 2008-2009
Table 56: Infectious Immunology Market, South Africa, Category Contribution (%), 2009
Table 57: Infectious Immunology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 58: Infectious Immunology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 59: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 60: Infectious Immunology, South Africa, Company Share by Revenue ($m), 2008-2009
Table 61: Microbiology Culture Market, South Africa, Category Contribution (%), 2009
Table 62: Microbiology Culture, South Africa, Revenue ($m) by Segment, Historic, 2002-2009
Table 63: Microbiology Culture, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016
Table 64: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 65: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 66: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), 2008-2009
Table 67: Microbiology Culture, South Africa, Company Share by Revenue ($m), 2008-2009
Table 68: Clinical Chemisty Market Pipeline Products
Table 69: Immuno Chemistry Market Pipeline Products
Table 70: Haematology Market Pipeline Products
Table 71: Infectious Immunology Market Pipeline Products
Table 72: Microbiology Culture Market Pipeline Products
Table 73: Histology and Cytology Market Pipeline Products
Table 74: Genetic Testing Market Pipeline Products
Table 75: QIAGEN Enters Into Distribution Agreement With Celera
Table 76: Sequenom Enters Into Licensing Agreement With Optherion
Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
Table 78: OraSure Technologies Enters Into An Agreement With Roche Diagnostics
Table 79: HairDX Enters Into Distribution Agreement With HairOptions
Table 80: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
Table 81: USD to Local Currency, South Africa, Average Actual Rate 2002-2009